leapcure’s Post

Contracts and budgets are imperative to the clinical trial startup. That’s why it’s important to come together and discuss communication gaps and gain the perspective from sponsors, sites and CROs as we have one goal in mind - get a study up and running and bring treatment to patients as quickly as possible. I am attending the 4th Clinical Trial Agreements Forum hosted by Dynamic Global Events (DGE). This is the only forum (that I’ve found) that is specific to CTAs. The discussions have been invaluable and this is my second time attending. If you are in Clinical, especially the contracting/budgeting space, I urge you to check it out next year! #DGEvents #clinicaltrialagreements

Come learn more about what KPH has to offer! 💙🧡💙🧡

A Phase 1 clinical trial aims to assess the drug’s safety and dosage and enable the design of Phase 2 and the rest of the clinical trial phases. Here's what you need to know about designing a successful phase 1 clinical trial: https://lnkd.in/gpQ2z4UB

This is vital information for anyone in #regulatorycompliance #regulatoryaffairs for #fdacompliance #fdaapproval #fdaregulations #FDA as it pertains to #clinicaltrials and #clinicalresearch - #shareknowledge

Are you running a Decentralised Clinical Trial? Almac is an industry leader in managing clinical trial supplies, for people at home, in places all over the world. Through Almac to Patient, sponsors have the ability to reach diverse patient populations and reduce the burden for people taking part in clinical trials. Find out how Almac can support your Decentralised Clinical Trial: https://hubs.li/Q02wFsxx0

Earlier this year, the FDA released Draft Guidelines on Decentralised Clinical Trials, offering valuable insights for the clinical trial industry, investigators, and stakeholders. We prioritise patient well-being in clinical trials, ensuring exceptional experiences and outcomes. In our latest blog, we delve into the patient perspective of these industry-wide guidelines for Decentralised Clinical Trials: https://ow.ly/vfTN50QaXoW #ClinicalTrials #PatientPerspective #FDA #HealthcareEthics

🔬How can sites secure more studies as competition gets fiercer? Explore the key strategies for maintaining a steady study pipeline in a highly competitive environment in our blog, "How to Attract Sponsors & CROs: 3 Lessons from Top Clinical Trial Sites." Discover how to fortify your site's position and secure more studies with these essential tactics: ✅ 𝐇𝐢𝐠𝐡 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐧𝐫𝐨𝐥𝐥𝐦𝐞𝐧𝐭: the pivotal role of patient recruitment in enhancing site performance and attracting study opportunities. ✅ 𝐂𝐥𝐞𝐚𝐧 𝐃𝐚𝐭𝐚: Explore the importance of maintaining clean and trackable data to showcase your site's research efficacy and reliability. ✅ 𝐒𝐭𝐫𝐞𝐚𝐦𝐥𝐢𝐧𝐞𝐝 𝐏𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬: Learn how standardized, streamlined processes can optimize your site's efficiency and bolster its overall quality. Enhancing these core aspects will not only elevate your site's consistency and quality but also build a strong reputation, drawing the attention of prominent sponsors and CROs. Discover how you can implement these strategies and elevate your clinical site's performance right here: https://lnkd.in/gsRw69mK #ClinicalTrials #ClinicalResearch #BetterData #Compliance #FDACompliance

Large-Scale Clinical Trial Management Protocol | Template By Aries Hilton A world changing publication: “102 min read“. This protocol outlines a framework for managing large-scale clinical trials involving 100,000+ participants across 100+ facilities. It addresses key areas to ensure a successful, well-coordinated, and ethically sound research endeavor. SunSiteVR #NIH #cognitivereality

There are two weeks to go until our webinar: Insider Perspectives on the Clinical Trials Regulation in Early Phase Trials After One Year. 🎙️ 🔎 March 26, 3pm CET. Jelle Klein will be joined by our client Boehringer Ingelheim's, Clinical Trial Manager, Nelly Van Mieghem, to assess our data, one year on from Clinical Trials Regulation (CTR), and explore the impact on timelines, alleviate concerns about potential delays, and gain insights into ongoing progress. Register now 👉 https://bit.ly/43g14Fp #clinicalresearch #CTR

As the drug development landscape evolves, we are seeing increased interest in areas such as Real-World Evidence, Patient-Focused Drug Development, and innovative clinical trial designs. FDA's upcoming workshop on Complex Innovative Design (CIDs) should be informative. CIDs can help us arrive at optimal study designs for the populations of interest.